Standard vaccines increase HIV-1 transcription during antiretroviral therapy
- 24 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 30 (15) , 2289-2298
Abstract
Objectives: Curative strategies using agents to perturb the HIV reservoir have demonstrated only modest activity, whereas increases in viremia after standard vaccination have been described. We investigated whether vaccination against non-HIV pathogens can induce HIV transcription and thereby play a role in future eradication strategies. Design: A randomized controlled trial (NCT00329251) was performed to compare the effects of clinical vaccines with placebo on HIV transcription and immune activation. Methods: Twenty-six HIV-infected individuals on suppressive antiretroviral therapy were randomized to receive a vaccination schedule (n = 13) or placebo (n = 13). Cell-associated RNA and DNA were extracted from peripheral blood mononuclear cells, and HIV was quantified by droplet digital PCR using primers for gag and 2-LTR (for HIV DNA), unspliced gag RNA (gag usRNA), multispliced tat-rev RNA (tat-rev msRNA) and polyA mRNA. Results: Significant increases in gag usRNA after influenza/hepatitis B vaccination (P = 0.02) and in gag usRNA (P = 0.04) and polyA mRNA (P = 0.04) after pneumococcus/hepatitis B vaccination were seen in vaccinees but not controls. HIV DNA and plasma HIV RNA did not change in either group. Increases in CD4+ and CD8+ T-cell activation markers (P = 0.08 and P < 0.001, respectively) and HIV-specific CD8+ responses (P = 0.04 for p24 gag, P = 0.01 for p17 gag and P = 0.04 for total gag) were seen in vaccinees but not controls. Conclusion: In this study, vaccination was associated with increases in HIV cell-associated RNA and HIV-specific responses during antiretroviral therapy. Using standard vaccines to stimulate HIV transcription may therefore be a useful component of future eradication strategies.Keywords
This publication has 55 references indexed in Scilit:
- Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsThe Lancet, 2013
- Cell-associated HIV RNA: a dynamic biomarker of viral persistenceRetrovirology, 2013
- Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV LatencyPLOS Pathogens, 2012
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus ReactivationImmunity, 2012
- Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic statusVaccine, 2011
- Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy OutcomePLOS ONE, 2009
- The Challenge of Finding a Cure for HIV InfectionScience, 2009
- Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T CellsPLOS Pathogens, 2006
- Pneumococcal Vaccination of HIV-Infected Individuals: Safety and EfficacyAIDS Patient Care and STDs, 1997
- Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral loadAIDS, 1994